Language

Current issue
Free subscription

7.4-13

Value of contrast-enhanced mri for risk-stratification of sudden cardiac death in different patients with structural heart disease.

Zhambeev A.A., Gasparyan A.Zh., Stukalova O.V., Shlevkov N.B.

Magnetic resonance imaging (MRI) with intravenous gadolinium chelate is considered the most informative method of examination of patients with a high risk of sudden cardiac death (SCD). It allows the most accurate estimation the parameters of structural myocardial damage, identifying zones of fibrosis and scar lesions. In recent years there has been a lot of studies devoted to prognostic evaluation of late gadolinium enhancement cardiac MRI (LGE-MRI) in patients with high risk of SCD. This article summarizes the current published data of the use LGE-MRI for risk stratification of SCD and for preselection of patients that can benefit from cardioverter-defibrillators implantation in patients with coronary heart disease (CHD), hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM).
Myasnikov A.L Institute of Clinical Cardiology, Russian Cardiological Centre. National research medical University, department of molecular pharmacology and radiobiology. Moscow, Russia.


 

 

 

 

 

 

Keywords:cardiac magnetic resonance imaging, late gadolinium enhancement, sudden cardiac death, ventricular tachycardia.

 

Corresponding author:Zhambeev A.A., e-mail: Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript

 

For citation: Zhambeev A.A., Gasparyan A.Zh., Stukalova O.V., Shlevkov N.B. Value of contrast-enhanced mri for risk-stratification of sudden cardiac death in different patients with structural heart disease. REJR 2017; 7(4):130-139. DOI:10.21569/2222-7415-2017-7-4-130-139.

Received: 23.10.2017 Accepted: 08.11.2017